Comparative metabolism of THCA and THCV using UHPLC-Q-Exactive Orbitrap-MS

References

• Anderson LL, Low IK, Banister SD, McGregor IS, Arnold JC. 2019. Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet syndrome. J Nat Prod. 82(11):3047–3055.
   PubMed Web of Science ®Google Scholar
• Arulselvan P, Fard MT, Tan WS, Gothai S, Fakurazi S, Norhaizan ME, Kumar SS. 2016. Role of antioxidants and natural products in inflammation. Oxid Med Cell Longev. 2016:5276130.
   PubMed Web of Science ®Google Scholar
• Corona G, Rizzolio F, Giordano A, Toffoli G. 2012. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets. J Cell Physiol. 227(7):2827–2831.
   PubMed Web of Science ®Google Scholar
• Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, et al. 2014. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 55(6):791–802.
   PubMed Web of Science ®Google Scholar
• Doorn JA, Florang VR, Schamp JH, Vanle BC. 2014. Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons. Parkinsonism Relat Disord. 20:S73–S75.
   PubMedGoogle Scholar
• Ezraty B, Gennaris A, Barras F, Collet JF. 2017. Oxidative stress, protein damage and repair in bacteria. Nat Rev Microbiol. 15(7):385–396.
   PubMed Web of Science ®Google Scholar
• Fan XF, Lin L, Cui BX, Zhao TM, Mao LH, Song Y, Wang XY, Feng HJ, Qingxiang Y, Zhang J, et al. 2020. Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: more friend than foe. Pharmacol Res. 159:104945.
   PubMed Web of Science ®Google Scholar
• Gaston TE, Friedman D. 2017. Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy Behav. 70(Pt B):313–318.
   PubMed Web of Science ®Google Scholar
• Greineisen WE, Turner H. 2010. Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists. Int Immunopharmacol. 10(5):547–555.
   PubMed Web of Science ®Google Scholar
• Grilo NM, Charneira C, Pereira SA, Monteiro EC, Marques MM, Antunes AMM. 2014. Bioactivation to an aldehyde metabolite – possible role in the onset of toxicity induced by the anti-HIV drug abacavir. Toxicol Lett. 224(3):416–423.
   PubMed Web of Science ®Google Scholar
• Hu DD, Chen XL, Xiao XR, Wang YK, Liu F, Zhao Q, Li X, Yang XW, Li F. 2018. Comparative metabolism of tripolide and triptonide using metabolomics. Food Chem Toxicol. 115:98–108.
   PubMed Web of Science ®Google Scholar
• Jinsmaa Y, Florang VR, Rees JN, Anderson DG, Strack S, Doorn JA. 2009. Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate. Chem Res Toxicol. 22(5):835–841.
   PubMed Web of Science ®Google Scholar
• Leung L, Kalgutkar AS, Obach RS. 2012. Metabolic activation in drug-induced liver injury. Drug Metab Rev. 44(1):18–33.
   PubMed Web of Science ®Google Scholar
• Li J, Mi YL, Wang SJ, Zhu XW, Wan HHM, Wang SF, Du W, Su C, Ma W, Chen SL, et al. 2022. Quantitative analysis of six cannabinoids in hemp based on UPLC-QQQ-MS/MS. Chin Tradit Herb Drugs. 53:1163–1172.
   Google Scholar
• Morales P, Hurst DP, Reggio PH. 2017. Molecular targets of the phytocannabinoids: a complex picture. Prog Chem Org Nat Prod. 103:103–131.
   PubMedGoogle Scholar
• Moreno-Sanz G. 2016. Can you pass the acid test? Critical review and novel therapeutic perspectives of Δ9-tetrahydrocannabinolic acid A. Cannabis Cannabinoid Res. 1(1):124–130.
   PubMedGoogle Scholar
• Nadal X, Rio CD, Casano S, Palomares B, Ferreiro-Vera C, Navarrete C, Sanchez-Carnerero C, Cantarero I, Bellido ML, Meyer S, et al. 2017. Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity. Br J Pharmacol. 174(23):4263–4276.
   PubMed Web of Science ®Google Scholar
• Nigro E, Formato M, Crescente G, Daniele A. 2021. Cancer initiation, progression and resistance: are phytocannabinoids from Cannabis sativa L. promising compounds? Molecules. 26(9):2668.
   PubMed Web of Science ®Google Scholar
• Palomares B, Ruiz-Pino F, Garrido-Rodriguez M, Eugenia Prados M, Sánchez-Garrido MA, Velasco I, Vazquez MJ, Nadal X, Ferreiro-Vera C, Morrugares R, et al. 2020. Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity. Biochem Pharmacol. 171:113693.
   PubMed Web of Science ®Google Scholar
• Park JY, Lee HJ, Kwon YS, Chun W. 2020. 3,4,5-Trihydroxycinnamic acid inhibits LPS-induced inflammatory response by increasing SIRT1 expression in human umbilical vein endothelial cells. J Vasc Res. 57(5):302–310.
   PubMed Web of Science ®Google Scholar
• Pertwee RG. 2008. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta 9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 153(2):199–215.
   PubMed Web of Science ®Google Scholar
• Rao QR, Zhang T, Dai MY, Li B, Pu QL, Zhao M, Cheng Y, Yan DM, Zhao Q, Wu EZ, et al. 2022. Comparative metabolomic profiling of the metabolic difference of Δ9-tetrahydrocannabinol and cannabidiol. Molecules. 27(21):7573.
   PubMed Web of Science ®Google Scholar
• Reichel A. 2009. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept. Chem Biodivers. 6(11):2030–2049.
   PubMed Web of Science ®Google Scholar
• Romano B, Pagano E, Orlando P, Capasso R, Cascio MG, Pertwee R, Marzo VD, Izzo AA, Borrelli F. 2016. Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages. Pharmacol Res. 113:199–208.
   PubMed Web of Science ®Google Scholar
• Skell JM, Kahn M, Foxman BM. 2021. Δ(9)-Tetrahydrocannabinolic acid A, the precursor to Δ(9)-tetrahydrocannabinol (THC). Acta Crystallogr C Struct Chem. 77(2):84–89.
   PubMed Web of Science ®Google Scholar
• Smart R, Pacula RL. 2019. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: findings from state policy evaluations. Am J Drug Alcohol Abuse. 45(6):644–663.
   PubMed Web of Science ®Google Scholar
• Stresemann C, Lyko F. 2008. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer. 123(1):8–13.
   PubMed Web of Science ®Google Scholar
• Urano Y, Mori C, Fuji A, Konno K, Yamamoto T, Yashirogi S, Ando M, Saito Y, Noguchi N. 2018. 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway. Autophagy. 14(11):1943–1958.
   PubMed Web of Science ®Google Scholar
• Vastag M, Keseru GM. 2009. Current in vitro and in silico models of blood–brain barrier penetration: a practical view. Curr Opin Drug Discov Devel. 12(1):115–124.
   PubMed Web of Science ®Google Scholar
• Wang K, Lin DJ, Guo XC, Huang WL, Peng Y, Zheng J. 2017. Chemical identity of interaction of protein with reactive metabolite of diosbulbin B in vitro and in vivo. Toxins. 9(8):249.
   PubMed Web of Science ®Google Scholar
• Wang YK, Li WQ, Xia S, Guo L, Miao Y, Zhang BK. 2021. Metabolic activation of the toxic natural products from herbal and dietary supplements leading to toxicities. Front Pharmacol. 12:758468.
   PubMed Web of Science ®Google Scholar
• Wang YK, Xiao XR, Xu KP, Li F. 2018. Metabolic profiling of the anti-tumor drug regorafenib in mice. J Pharm Biomed Anal. 159:524–535.
   PubMed Web of Science ®Google Scholar
• Xiong GL, Wu ZX, Yi JC, Fu L, Yang ZJ, Hsieh CY, Yin MZ, Zeng XX, Wu CK, Lu AP, et al. 2021. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 49(W1):W5–W14.
   PubMed Web of Science ®Google Scholar
• Yin J, Ren WK, Yang G, Duan JL, Huang XG, Fang RJ, Li CY, Li TJ, Yin YL, Hou YQ, et al. 2016. l-Cysteine metabolism and its nutritional implications. Mol Nutr Food Res. 60(1):134–146.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hu QF, Ma XP, Sun WX, Xing JB. 2019. Content determination of five cannabinoids in flowers and leaves of Cannabis sativa by HPLC. J Chin Med Mater. 42:1824–1827.
   Google Scholar
• Zhao Q, Zhang T, Xiao XR, Huang JF, Wang Y, Gonzalez FJ, Li F. 2019. Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity. Br J Pharmacol. 176(13):2162–2178.
   PubMed Web of Science ®Google Scholar
• Zhao XJ, Fritsche J, Wang JS, Chen J, Rittig K, Schmitt-Kopplin P, Fritsche A, Haring HU, Schleicher ED, Xu GW, et al. 2010. Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics. 6(3):362–374.
   PubMed Web of Science ®Google Scholar